hydralazine has been researched along with Arteriovenous Malformations in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Arteriovenous Malformations: Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| James, DJ | 1 |
| Bedford, RF | 1 |
| Milhorat, TH | 1 |
2 other studies available for hydralazine and Arteriovenous Malformations
| Article | Year |
|---|---|
Hydralazine for controlled hypotension during neurosurgical operations.
Topics: Adult; Arteriovenous Malformations; Brain Neoplasms; Enflurane; Humans; Hydralazine; Hypotension, Co | 1982 |
Intracerebral hemorrhage, acute hydrocephalus, and systemic hypertension.
Topics: Arteriovenous Malformations; Carotid Arteries; Cerebral Hemorrhage; Cerebral Ventriculography; Cereb | 1971 |